Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Nucleotides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global nucleotides market size reached US$ 667.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 995.3 Million by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.

Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.

Nucleotides Market Trends:

At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleotides market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, form and application.

Breakup by Type:

  • Food Grade
  • Lab Grade
  • Industry Grade
  • Others
     

Breakup by Technology:

  • TaqMan Allelic Discrimination
  • Gene Chips and Microarrays
  • SNP by Pyrosequencing
  • Others
     

Breakup by Form:

  • Liquid
  • Powder
     

Breakup by Application:

  • Pharmaceutical
  • Food and Animal Feed Additives
  • Drug Discovery
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
    Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Million
Segment Coverage Type, Technology, Form, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global nucleotides market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nucleotides market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the form?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nucleotides market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Nucleotides Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Food Grade
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Lab Grade
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Industry Grade
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Technology
    7.1    TaqMan Allelic Discrimination
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Gene Chips and Microarrays
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    SNP by Pyrosequencing
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Form
    8.1    Liquid
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Powder
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Application
    9.1    Pharmaceutical
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Food and Animal Feed Additives
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Drug Discovery
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    CJ CheilJedang Corporation
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Exotic Biosolutions
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    F. Hoffmann-La Roche AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
        15.3.4    Jena Bioscience GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Koninklijke DSM N.V.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Lallemand Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Meridian Bioscience Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Nanjing Biotogether Co. Ltd.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Ohly GmbH (Associated British Foods plc)
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Promega Corporation
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Starlake Bioscience Co. Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
        15.3.12    Thermo Fisher Scientific Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report 

List of Figures

Figure 1: Global: Nucleotides Market: Major Drivers and Challenges
Figure 2: Global: Nucleotides Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Nucleotides Market: Breakup by Type (in %), 2022
Figure 5: Global: Nucleotides Market: Breakup by Technology (in %), 2022
Figure 6: Global: Nucleotides Market: Breakup by Form (in %), 2021
Figure 7: Global: Nucleotides Market: Breakup by Application (in %), 2022
Figure 8: Global: Nucleotides Market: Breakup by Region (in %), 2022
Figure 9: Global: Nucleotides (Food Grade) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Nucleotides (Food Grade) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Nucleotides (Lab Grade) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Nucleotides (Lab Grade) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Nucleotides (Industry Grade) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Nucleotides (Industry Grade) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Nucleotides (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Nucleotides (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Nucleotides (TaqMan Allelic Discrimination) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Nucleotides (TaqMan Allelic Discrimination) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Nucleotides (Gene Chips and Microarrays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Nucleotides (Gene Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Nucleotides (SNP by Pyrosequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Nucleotides (SNP by Pyrosequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Nucleotides (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Nucleotides (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Nucleotides (Liquid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Nucleotides (Liquid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Nucleotides (Powder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Nucleotides (Powder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Nucleotides (Pharmaceutical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Nucleotides (Pharmaceutical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Nucleotides (Food and Animal Feed Additives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Nucleotides (Food and Animal Feed Additives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Nucleotides (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Nucleotides (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Nucleotides (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Nucleotides (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Nucleotides Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Nucleotides Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Nucleotides Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Nucleotides Industry: SWOT Analysis
Figure 87: Global: Nucleotides Industry: Value Chain Analysis
Figure 88: Global: Nucleotides Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Nucleotides Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Nucleotides Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Nucleotides Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Nucleotides Market Forecast: Breakup by Form (in Million US$), 2023-2028
Table 5: Global: Nucleotides Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Nucleotides Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Nucleotides Market: Competitive Structure
Table 8: Global: Nucleotides Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4